new Alzheimer's drug, Exelon (rivastigmine)
June 2000
You'll be hearing a lot about the new Alzheimer's drug, Exelon (rivastigmine) from Novartis.
Exelon is a cholinesterase inhibitor...similar to Aricept.
These drugs offer modest benefits for patients with mild to moderate Alzheimer's. They may slightly improve cognitive abilities and delay the need for nursing home placement.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive